DRI Healthcare Trust (TSE:DHT.UN – Free Report) had its price objective lowered by Truist Financial from C$17.00 to C$14.00 in a research report report published on Thursday morning, BayStreet.CA reports.
A number of other analysts have also recently weighed in on the stock. CIBC lowered their price target on shares of DRI Healthcare Trust from C$20.00 to C$18.50 in a report on Tuesday, July 9th. National Bankshares lowered their price target on shares of DRI Healthcare Trust from C$23.50 to C$17.50 and set an outperform rating on the stock in a report on Tuesday, July 9th. Stifel Nicolaus cut shares of DRI Healthcare Trust from a buy rating to a hold rating and lowered their price target for the company from C$22.00 to C$15.00 in a report on Tuesday, July 9th. Royal Bank of Canada decreased their price objective on shares of DRI Healthcare Trust from C$20.00 to C$16.00 in a research report on Tuesday, July 9th. Finally, Canaccord Genuity Group decreased their price objective on shares of DRI Healthcare Trust from C$19.50 to C$19.00 and set a buy rating for the company in a research report on Wednesday, May 8th. One research analyst has rated the stock with a hold rating and six have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of Moderate Buy and a consensus price target of C$18.50.
Check Out Our Latest Stock Report on DHT.UN
DRI Healthcare Trust Price Performance
DRI Healthcare Trust Increases Dividend
The company also recently announced a quarterly dividend, which was paid on Friday, July 19th. Stockholders of record on Friday, July 19th were issued a dividend of $0.085 per share. This represents a $0.34 annualized dividend and a dividend yield of 2.83%. This is a positive change from DRI Healthcare Trust’s previous quarterly dividend of $0.08. The ex-dividend date was Friday, June 28th. DRI Healthcare Trust’s payout ratio is 17.34%.
About DRI Healthcare Trust
DRI Healthcare Trust focuses on managing and growing a portfolio of pharmaceutical royalties. It owns a portfolio of 18 royalties derived from the sale of 14 various pharmaceutical products that focuses on eight therapeutic areas. The company was incorporated in 2020 and is headquartered in Toronto, Canada.
Read More
- Five stocks we like better than DRI Healthcare Trust
- How to Calculate Return on Investment (ROI)
- Is Crypto Cool Again? What Stocks You Should Be Watching
- The Most Important Warren Buffett Stock for Investors: His Own
- Why Call Options Volume for These 2 Stocks Spiked Together
- What is a Low P/E Ratio and What Does it Tell Investors?
- MarketBeat Week in Review – 7/22 – 7/26
Receive News & Ratings for DRI Healthcare Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DRI Healthcare Trust and related companies with MarketBeat.com's FREE daily email newsletter.